Solomon Endlich is a physicist making waves in Biotechnology. He spun Base5 Genomics out of his postdoctoral work on genome sequencing in the Morrison lab at Stanford University. He has over 10 years of research experience in theoretical physics and molecular biology. Solomon is passionate about solving challenging issues that have the power to propel us into the next era of precision medicine. When he isnt in the lab you can find him climbing in Yosemite, scuba diving in Monterey or chasing his deaf rescue dog Silas around Palo Alto.
Powering precision medicine with panimmunogenomic reference graphs
Precision medicine requires precision genomics, especially in the most clinically relevant, polymorphic, and previously unresolved immunogenomic regions like the MHC. Base5 Genomics has created the most complete panimmunogenomic reference graphs comprising fulllength, fully contiguous, and haplotypephased sequences of the MHC and other immunogenomic regions. Immediate applications are discussed.
Genomic Profiling Showcase:
Base5 Genomics, Inc.
Base5 Genomics' immunogenomic platform is leading precision medicine into a new era. Base5 delivers contextualized biological ground truth with patient-specific genomic references that capture the most challenging and clinically important regions of the human genome.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 Genomic Profiling Showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.